Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 0
- Grants since 2016
- 1 073
Grants received
2024–2025 · award
How the aging tumor microenvironment affects the outgrowth of leptomeningeal metastases
Inna Smalley · Moffitt Cancer Center · funded by American Cancer Society
2024–2029 · research · R35
Dissecting enhancer function through integrative genomics
Mingxiang Teng · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R21
Targeting a PHGDH metabolic vulnerability in melanoma
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Defining impact of in situ activation of CD40 and type 1 interferon signaling on theTME and systemic T cell immunity in murine models and cancer patients
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Selective targeting of TAF1 function in acute myeloid leukemia
Jiandong Chen · Moffitt Cancer Center · funded by National Institutes of Health
2024–2027 · award
Tumor-Reactive T Cells To Treat Melanoma Leptomeningeal Disease
Yolanda Pina · Moffitt Cancer Center · funded by Melanoma Research Alliance
2024–2029 · research · R01
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Brian D Gonzalez · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R21
L-fucose-mediated enrichment of memory CD4+T cells and enhanced anti-melanoma immunity
Eric Kirk Lau · Moffitt Cancer Center · funded by National Institutes of Health
2024–2025 · award
How the aging tumor microenvironment affects outgrowth of leptomeningeal metastases
Ana Patricia Da Silva Gomes · Moffitt Cancer Center · funded by American Cancer Society
2024–2029 · research · R37
Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
Fabiana Perna · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R01
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer
Alex Jaeger · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R01
Epigenetic and metabolic bottlenecks of tumorigenesis
Ana Da Silva Gomes · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R35
Dissecting enhancer function through integrative genomics
Mingxiang Teng · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Brian D Gonzalez · Moffitt Cancer Center · funded by National Institutes of Health
2024–2027 · research · R34
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R21
Development of adverse event (AE) derived biomarkers for predicting clinical outcomes in lung cancer
Dung-Tsa Chen · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Defining impact of in situ activation of CD40 and type 1 interferon signaling on theTME and systemic T cell immunity in murine models and cancer patients
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R01
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis
Seongseok Yun · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R37
Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
Fabiana Perna · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers
Jennifer L Hay · Moffitt Cancer Center · funded by National Institutes of Health
2024–2030 · research · R01
Suppression of progesterone receptor signaling by heavy metals promotes tamoxifen resistance and metastasis or ER+ breast cancer
Marcelo G. Bonini · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Selective targeting of TAF1 function in acute myeloid leukemia
Jiandong Chen · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-cell Therapy
Doris K Hansen · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Remodeling the Immune Landscape in Breast Cancer Leptomeningeal Disease Using Dendritic Cell Therapy is an Effective Treatment and Protects Against Disease Recurrence.
Brian Joseph Czerniecki · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R03
Investigating lipid phenotype as a metabolic adaptation to microenvironmental stress
Smitha R Pillai · Moffitt Cancer Center · funded by National Institutes of Health
2024–2026 · research · R21
Development of bifunctional CDK2 inhibitors for treatment of CCNE1-driven cancers
Justin Matthew Lopchuk · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Release of interleukin-1a as a mediator of immune evasion in cancer
Brian Ruffell · Moffitt Cancer Center · funded by National Institutes of Health
2024–2029 · cooperative agreement · U24
Developing a Cancer Galaxy Computational Workbench to Meet Emerging Cancer Data Analysis Needs
Jeremy Goecks · Moffitt Cancer Center · funded by National Institutes of Health
2024–2028 · research · R01
Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis
Doratha Armenthus Byrd · Moffitt Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
Fabiana Perna · Moffitt Cancer Center · funded by National Institutes of Health
2023–2028 · award
Prevention of Infection Related Cancers
Anna Giuliano · Moffitt Cancer Center · funded by American Cancer Society
2023–2028 · cooperative agreement · U01
Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)
Antonio Luigi Amelio · Moffitt Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma
Jose Alejandro Guevara-Patino · Moffitt Cancer Center · funded by National Institutes of Health
2023–2025 · research · R37
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
Issam M. El Naqa · Moffitt Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
Karen M Mann · Moffitt Cancer Center · funded by National Institutes of Health
2023–2026 · research · R21
Engineering model-based systems to monitor and steer subclonal dynamics
Noemi Andor · Moffitt Cancer Center · funded by National Institutes of Health
2023–2024 · research · R03
The role of HPV E1 in regulating the NRF2-KEAP1 pathway
Jennifer Binning · Moffitt Cancer Center · funded by National Institutes of Health
2023–2024 · research · R03
The role of HPV E1 in regulating the NRF2-KEAP1 pathway
Jennifer Binning · Moffitt Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Engineering model-based systems to monitor and steer subclonal dynamics
Noemi Andor · Moffitt Cancer Center · funded by National Institutes of Health
2023–2026 · research · R21
Adaptations of breast cancer metastasis to the aging lung
Ana Da Silva Gomes · Moffitt Cancer Center · funded by National Institutes of Health